Hostname: page-component-76d6cb85b7-lrvh5 Total loading time: 0 Render date: 2026-07-25T16:32:08.212Z Has data issue: false hasContentIssue false
  • English
  • Français

Survey of immunosuppressive acidic protein and other immunological parameters in head and neck cancer patients

Published online by Cambridge University Press:  29 June 2007

Tadashi Nakashima ,
Motosuke Tanaka  and
Sei-ichi Okamura
Tadashi Nakashima*
Affiliation:
Department of Otolaryngology, National Kyushu Cancer Centre, Notame 3-1-1, Minami-ku, Fukuoka 815, Japan.
Motosuke Tanaka
Affiliation:
Cancer Centre of Kyushu University Hospital, Notame 3-1-1, Minami-ku, Fukuoka 815, Japan.
Sei-ichi Okamura
Affiliation:
Cancer Centre of Kyushu University Hospital, Notame 3-1-1, Minami-ku, Fukuoka 815, Japan.
*
Tadashi Nakashima, M.D., Department of Otolaryngology, National Kyushu Cancer Centre, Notame 3-1-1, Minami-ku, Fukuoka 815, Japan.
Get access Rights & Permissions [Opens in a new window]

Abstract

Serum levels of immunosuppressive acidic protein (IAP) and other immunological parameters were examined in 95 head and neck cancer patients and 27 control patients. The mean values of IAP in patients in the advanced stage were significantly higher than in early stage patients. Statistically significant increases in the mean concentration of IAP were also observed in patients with a recurrence, as compared to findings in those in the advanced stages. The mean values of blastogenesis response to PHA and NK cell activity in the cancer patients were lower than in disease free individuals, but with no statistical differences. In the endstage patients, the lAP concentration was considerably elevated and the blastogenesis response showed a statistically significant decrease. Thus, the monitoring of serum lAP, in combination with other immunological parameters, aids in planning and assessing clinical staging in head and neck cancer patients.

Keywords

ImmunologyHead and neck cancerAcidic proteinimmunosuppressive

Information

Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 105 , Issue 11 , November 1991 , pp. 939 - 945
Copyright
Copyright © JLO (1984) Limited 1991

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Castelli, M., Salvati, F., Cruciani, A., Portalone, L., Giannarelli, D., Ferrini, U. (1989) Comparative Analysis of CEA and SCC serum IAP in human lung cancer. International Journal of Biological Markers, 4; 45–50.CrossRefGoogle ScholarPubMed
Gold, P., Freedman, S. O. (1965) Demonstration of tumour specific'antigens in human colonic carcinoma by immunological tolerance and absorptive techniques. Journal of Experimental Medicine, 121: 439–462.CrossRefGoogle ScholarPubMed
Hanna, E. N. Y., Papay, F. A., Gupta, M. K., Lavertu, P., Tucker, M. M. (1990) Serum tumour markers of head and neck cancer: Current status. Head and Neck, 12: 50–59.CrossRefGoogle ScholarPubMed
Itoh, Y., Fukumachi, I., Nakajima, K., Kawai, T., Nakano, K. (1983) A new method for the evaluation lymphocyte activation by ethidium bromide fluorescence assays. Igaku no Ayumi, 126: 21–22.Google Scholar
Kikuchi, K., Gotoh, H., Kowada, M. (1987) Immunosuppressive acidic protein in patients with brain tumours. Acta Neurochirurgica, 86: 42–49.CrossRefGoogle ScholarPubMed
Mancini, G., Carbonara, A. P., Hermans, J. E. (1965) Immunochemical quantification of antigen by single radial immunodiffusion. Immunochemistry, 2: 235–254.CrossRefGoogle Scholar
Miki, T., Saiki, S., Kinouchi, T., Kuroda, M., Kiyohara, H., Usami, M., Sawada, M., Kotake, T. (1987) Immunosuppressive acidic protein in patients with testicular cancer. Journal of Urology, 137: 48–52.CrossRefGoogle ScholarPubMed
Okamura, S., Hayashi, S., Asano, Y., Shibuya, T., Otsuka, T., Niho, Y. (1988) Expression of the granulocyte/macrophage colony-stimulating factor gene in leukemic blast cells from patients with acute non-lymphocytic leukemia. Biomedical Pharmacotherapy, 42: 65–68.Google ScholarPubMed
Okamura, S., Hayashi, S., Kawasaki, C., Kondo, S., Asano, Y., Harada, M., Niho, Y. (1989) Expression of cytokine genes in hematological malignancies. Acta Haematologica Japonica, 52: 1423–1432.Google ScholarPubMed
Okuda, K., The Liver Cancer Study Group of Japan. (1980) Primary liver cancers in Japan. Cancer, 45: 2663–2669.3.0.CO;2-G>CrossRefGoogle Scholar
Sawada, M., Okumura, Y., Matsui, Y., Shimizu, Y. (1983) Immunosuppressive acidic protein in patients with ovarian cancer. Cancer, 52: 2081–2985.3.0.CO;2-T>CrossRefGoogle ScholarPubMed
Sawada, M., Okudaira, Y., Matsui, Y., Shimizu, Y. (1984) Immunosuppressive acidic protein in patients with gynecologic cancer. Cancer, 54: 652–656.3.0.CO;2-C>CrossRefGoogle ScholarPubMed
Schantz, S. P., Brown, B. W., Lira, E., Taylor, D. L., Beddingfield, N. (1987) Evidence of the role of natural immunity in the control of metastatic spread of head and neck cancer. Cancer Immunology and Immunotherapy, 25: 141–145.CrossRefGoogle ScholarPubMed
Shibata, Y., Tamura, K., Ishida, N. (1983) In vivo analysis of the suppressive effects of immunosuppressive acidic protein, a type of acid glycoprotein, in connection with its high level in tumour-bearing mice. Cancer Research, 43: 2889–2896.Google Scholar
Snyderman, C. H., Heo, D. S., Chen, K., Whiteside, T. L., Johnson, J. T. (1989) T-cell markers in tumour infiltrating lymphocytes of head and neck cancer. Head and Neck, 11: 331–336.CrossRefGoogle ScholarPubMed
Tamura, K., Shibata, Y., Matsuda, Y., Ishida, N. (1981) Isolation and characterization of an immunosuppressive acidic protein from ascitic fluids of cancer patients. Cancer Research, 41: 3244–3252.Google ScholarPubMed
Tanaka, M., Nakashima, T., Komiyama, S., Uemura, T., Okamura, S. (1988) Immunological parameters in head and neck cancer patients. Otologicea Fukuoka, 34: 1188–1194.Google Scholar
Tancini, G., Barni, S., Rescaldani, R., Fiorelli, G., Viviani, S., Lissoni, P. (1990) T helper and suppressor lymphocyte subsets in relation to the clinical stage of solid neoplasms. Oncology, 47: 381–384.CrossRefGoogle Scholar
Wolf, G. T., Schmaltz, S., Hudson, J., Robson, H., Stackhouse, T., Peterson, K. A., Poore, J. A., McClatchey, K. D. (1987) T-lymphocyte subpopulations in patients with head and neck cancer. Archives of Otolarygnology—Head and Neck Surgery, 113: 1200–1206.CrossRefGoogle ScholarPubMed
Yamanaka, N., Harabuchi, Y., Himi, T., Kataura, A. (1988) Immunosuppressive substance in the sera of head and neck cancer patients. Cancer, 62: 1293–1298.3.0.CO;2-D>CrossRefGoogle ScholarPubMed
Yoda, Y., Abe, T., Mitamura, K., Saito, K., Kawada, K., Onozawa, Y., Adachi, Y., Nomura, T. (1982) Deficient natural killer (NK) cell activity in paroxysmal nocturnal haemoglobinuria (PNH). British Journal of Haematology, 52: 559–562.CrossRefGoogle ScholarPubMed